A new risk-assessment tool for venous thromboembolism in advanced lung cancer: a prospective, observational study

Management of cancer-associated venous thromboembolism (VTE) is essential in treatment selection and cancer prognosis. However, to date, there is no method to assess the risk of VTE specifically associated with advanced lung cancer. Our aim was to create a new risk assessment scoring system that can...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsubata, Yukari, Hotta, Takamasa, Hamai, Kosuke, Furuya, Naoki, Yokoyama, Toshihide, Saito, Ryota, Nakamura, Atsushi, Masuda, Takeshi, Hamaguchi, Megumi, Kuyama, Shoichi, Honda, Ryoichi, Senoo, Tadashi, Nakanishi, Masamoto, Yamasaki, Masahiro, Ishikawa, Nobuhisa, Fujitaka, Kazunori, Kubota, Tetsuya, Kobayashi, Kunihiko, Isobe, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981807/
https://www.ncbi.nlm.nih.gov/pubmed/35379309
http://dx.doi.org/10.1186/s13045-022-01259-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981807/
https://www.ncbi.nlm.nih.gov/pubmed/35379309
http://dx.doi.org/10.1186/s13045-022-01259-7

Ejemplares similares